11L Stock Overview
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Canopy Growth Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$3.86 |
| 52 Week High | CA$13.82 |
| 52 Week Low | CA$2.55 |
| Beta | 1.78 |
| 11 Month Change | 4.90% |
| 3 Month Change | -34.44% |
| 1 Year Change | -20.27% |
| 33 Year Change | -96.93% |
| 5 Year Change | -97.21% |
| Change since IPO | -84.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 11L | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -15.6% | -2.5% | -0.2% |
| 1Y | -20.3% | -14.4% | 12.9% |
Return vs Industry: 11L underperformed the German Pharmaceuticals industry which returned -16.7% over the past year.
Return vs Market: 11L underperformed the German Market which returned 12.5% over the past year.
Price Volatility
| 11L volatility | |
|---|---|
| 11L Average Weekly Movement | 12.0% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 11L's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 11L's weekly volatility has decreased from 21% to 12% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,029 | David Klein | www.canopygrowth.com |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices.
Canopy Growth Corporation Fundamentals Summary
| 11L fundamental statistics | |
|---|---|
| Market cap | €396.50m |
| Earnings (TTM) | -€403.85m |
| Revenue (TTM) | €192.50m |
2.1x
P/S Ratio-1.0x
P/E RatioIs 11L overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 11L income statement (TTM) | |
|---|---|
| Revenue | CA$287.10m |
| Cost of Revenue | CA$197.94m |
| Gross Profit | CA$89.17m |
| Other Expenses | CA$691.47m |
| Earnings | -CA$602.30m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.42 |
| Gross Margin | 31.06% |
| Net Profit Margin | -209.79% |
| Debt/Equity Ratio | 105.3% |
How did 11L perform over the long term?
See historical performance and comparison